The company got almost delisted from NASDAQ for "restating" (read - deceiving investors) their earnings. I would stay away from EDAP for now. Although if you went short on them a couple of years ago....smart move!
Why hasn't someone asked these guys for specific breakdowns of their sales volumes by product and country? They have no cash, questionable reporting and potential unreported problems with the FCC. Where is the update on the efficacy of HIFU? How many patients have they really done in their US FDA trial? Dump before they dilute the remaining stock to save their behinds.